Skip to content

Effectiveness of Platelet-Rich Plasma in Comparison to Conventional Myringoplasty Procedure

Assessing the Effectiveness of Autologous Platelet-Rich Plasma in Comparison to Conventional Myringoplasty Procedure:A Randomized Controlled Trial - NIL

Status
Recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078245
Enrollment
54
Registered
2024-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H661- Chronic tubotympanic suppurative otitis media

Interventions

Intervention1: Autologous Platelet Rich Plasma: Use of autologous platelet rich plasma in myringoplasty Control Intervention1: Normal Saline: Use of Normal Saline in myringoplasty

Sponsors

DrSharan Prakash
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All cases of tubotympanic type of chronic suppurative otitis media with perforation of the tympanic membrane with dry ear for a period of 3 weeks before day of surgery. 2. No evidence of active infection in nose,throat or paranasal sinuses. 3. Includes patient in the age group of 15-70 years.

Exclusion criteria

Exclusion criteria: 1. All cases of Attico antral type of CSOM. 2. Patients with age less than 15 years and more than 70 years of age. 3. Otogenic intra cranial complications in the past. 4. External ear infective condition. 5. Per operative ossicular discontinuity, fixed foot plate. 6. Patients with evidence of focal sepsis.

Design outcomes

Primary

MeasureTime frame
Tympanic membrane closure success rate assessed by otoscopy and tympanometry at specified follow-up intervals (e.g., 6 weeks & 3 months postsurgery).Timepoint: at 6 weeks and 3 months post surgery

Secondary

MeasureTime frame
Improvement in pure tone audiometry (PTA) thresholds, postoperative complications (e.g.,graft displacement, infection), and patient reported outcomes (e.g.,subjective hearing improvement, satisfaction with surgery). Timepoint: Within 6 weeks and 3 months post surgery

Countries

India

Contacts

Public ContactNISHANTH SAVERY

Aarupadai Veedu Medical College and Hospital

docnishuu@gmail.com9901515427

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026